400 related articles for article (PubMed ID: 26686578)
1. Drug-protein hydrogen bonds govern the inhibition of the ATP hydrolysis of the multidrug transporter P-glycoprotein.
Chufan EE; Kapoor K; Ambudkar SV
Biochem Pharmacol; 2016 Feb; 101():40-53. PubMed ID: 26686578
[TBL] [Abstract][Full Text] [Related]
2. Global alteration of the drug-binding pocket of human P-glycoprotein (ABCB1) by substitution of fifteen conserved residues reveals a negative correlation between substrate size and transport efficiency.
Vahedi S; Chufan EE; Ambudkar SV
Biochem Pharmacol; 2017 Nov; 143():53-64. PubMed ID: 28728917
[TBL] [Abstract][Full Text] [Related]
3. Effects of a detergent micelle environment on P-glycoprotein (ABCB1)-ligand interactions.
Shukla S; Abel B; Chufan EE; Ambudkar SV
J Biol Chem; 2017 Apr; 292(17):7066-7076. PubMed ID: 28283574
[TBL] [Abstract][Full Text] [Related]
4. ATP-dependent thermostabilization of human P-glycoprotein (ABCB1) is blocked by modulators.
Lusvarghi S; Ambudkar SV
Biochem J; 2019 Dec; 476(24):3737-3750. PubMed ID: 31774117
[TBL] [Abstract][Full Text] [Related]
5. Cooperativity between verapamil and ATP bound to the efflux transporter P-glycoprotein.
Ledwitch KV; Gibbs ME; Barnes RW; Roberts AG
Biochem Pharmacol; 2016 Oct; 118():96-108. PubMed ID: 27531061
[TBL] [Abstract][Full Text] [Related]
6. Interactions of the multidrug resistance modulators tariquidar and elacridar and their analogues with P-glycoprotein.
Pajeva IK; Sterz K; Christlieb M; Steggemann K; Marighetti F; Wiese M
ChemMedChem; 2013 Oct; 8(10):1701-13. PubMed ID: 23943604
[TBL] [Abstract][Full Text] [Related]
7. Multiple transport-active binding sites are available for a single substrate on human P-glycoprotein (ABCB1).
Chufan EE; Kapoor K; Sim HM; Singh S; Talele TT; Durell SR; Ambudkar SV
PLoS One; 2013; 8(12):e82463. PubMed ID: 24349290
[TBL] [Abstract][Full Text] [Related]
8. Human-Mouse Chimeras with Normal Expression and Function Reveal That Major Domain Swapping Is Tolerated by P-Glycoprotein (ABCB1).
Pluchino KM; Hall MD; Moen JK; Chufan EE; Fetsch PA; Shukla S; Gill DR; Hyde SC; Xia D; Ambudkar SV; Gottesman MM
Biochemistry; 2016 Feb; 55(7):1010-23. PubMed ID: 26820614
[TBL] [Abstract][Full Text] [Related]
9. Evidence for the critical role of transmembrane helices 1 and 7 in substrate transport by human P-glycoprotein (ABCB1).
Sajid A; Lusvarghi S; Chufan EE; Ambudkar SV
PLoS One; 2018; 13(9):e0204693. PubMed ID: 30265721
[TBL] [Abstract][Full Text] [Related]
10. Influence of breast cancer resistance protein (Abcg2) and p-glycoprotein (Abcb1a) on the transport of imatinib mesylate (Gleevec) across the mouse blood-brain barrier.
Bihorel S; Camenisch G; Lemaire M; Scherrmann JM
J Neurochem; 2007 Sep; 102(6):1749-1757. PubMed ID: 17696988
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of allosteric modulation of P-glycoprotein by transport substrates and inhibitors.
Dastvan R; Mishra S; Peskova YB; Nakamoto RK; Mchaourab HS
Science; 2019 May; 364(6441):689-692. PubMed ID: 31097669
[TBL] [Abstract][Full Text] [Related]
12. Thiol-reactive drug substrates of human P-glycoprotein label the same sites to activate ATPase activity in membranes or dodecyl maltoside detergent micelles.
Loo TW; Clarke DM
Biochem Biophys Res Commun; 2017 Jul; 488(4):573-577. PubMed ID: 28533092
[TBL] [Abstract][Full Text] [Related]
13. Elacridar enhances the cytotoxic effects of sunitinib and prevents multidrug resistance in renal carcinoma cells.
Sato H; Siddig S; Uzu M; Suzuki S; Nomura Y; Kashiba T; Gushimiyagi K; Sekine Y; Uehara T; Arano Y; Yamaura K; Ueno K
Eur J Pharmacol; 2015 Jan; 746():258-66. PubMed ID: 25455500
[TBL] [Abstract][Full Text] [Related]
14. Differential Coupling of Binding, ATP Hydrolysis, and Transport of Fluorescent Probes with P-Glycoprotein in Lipid Nanodiscs.
Li MJ; Nath A; Atkins WM
Biochemistry; 2017 May; 56(19):2506-2517. PubMed ID: 28441502
[TBL] [Abstract][Full Text] [Related]
15. Evidence for the Interaction of A
Abel B; Tosh DK; Durell SR; Murakami M; Vahedi S; Jacobson KA; Ambudkar SV
Mol Pharmacol; 2019 Aug; 96(2):180-192. PubMed ID: 31127007
[TBL] [Abstract][Full Text] [Related]
16. Substrate-induced conformational changes in the nucleotide-binding domains of lipid bilayer-associated P-glycoprotein during ATP hydrolysis.
Zoghbi ME; Mok L; Swartz DJ; Singh A; Fendley GA; Urbatsch IL; Altenberg GA
J Biol Chem; 2017 Dec; 292(50):20412-20424. PubMed ID: 29018094
[TBL] [Abstract][Full Text] [Related]
17. Modulation of the brain distribution of imatinib and its metabolites in mice by valspodar, zosuquidar and elacridar.
Bihorel S; Camenisch G; Lemaire M; Scherrmann JM
Pharm Res; 2007 Sep; 24(9):1720-8. PubMed ID: 17380257
[TBL] [Abstract][Full Text] [Related]
18. A mutation within the extended X loop abolished substrate-induced ATPase activity of the human liver ATP-binding cassette (ABC) transporter MDR3.
Kluth M; Stindt J; Dröge C; Linnemann D; Kubitz R; Schmitt L
J Biol Chem; 2015 Feb; 290(8):4896-4907. PubMed ID: 25533467
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and Characterization of Bodipy-FL-Cyclosporine A as a Substrate for Multidrug Resistance-Linked P-Glycoprotein (ABCB1).
Sajid A; Raju N; Lusvarghi S; Vahedi S; Swenson RE; Ambudkar SV
Drug Metab Dispos; 2019 Oct; 47(10):1013-1023. PubMed ID: 31371421
[TBL] [Abstract][Full Text] [Related]
20. Reversal of multidrug resistance by Marsdenia tenacissima and its main active ingredients polyoxypregnanes.
To KKW; Wu X; Yin C; Chai S; Yao S; Kadioglu O; Efferth T; Ye Y; Lin G
J Ethnopharmacol; 2017 May; 203():110-119. PubMed ID: 28363522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
